Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
Bosses at six water firms had £4m in bonuses blocked under new rules, Ofwat says
5/11/2025
Van de Ven brushes off Frank snub and reflects on his Spurs wonder goal
5/11/2025
A PowerWash Simulator sequel is exactly what we need right now
5/11/2025
Fruit, pistachio and matcha cakes : Philip Khoury’s loaf recipes
5/11/2025
Sali Hughes on beauty : the best new products to keep your skin glowing this autumn and beyond
5/11/2025
The ‘pavement vigilante’ : why Cameron Roh is naming and shaming bad walking etiquette
5/11/2025